Disease detection methodologies in relapsed B-cell acute lymphoblastic leukemia: Opportunities for improvement.

Background: Accurate disease detection is integral to risk stratification in B-cell acute lymphoblastic leukemia (ALL). The gold standard used to evaluate response in the United States includes morphologic evaluation and minimal residual disease (MRD) testing of aspirated bone marrow (BM) by flow cy...

Descripción completa

Detalles Bibliográficos

Publicado en:	Pediatric Blood & Cancer Vol. 67; no. 4; pp. 1 - 9
Autores principales:	Shalabi, Haneen, Yuan, Constance M., Kulshreshtha, Amita, Dulau‐Florea, Alina, Salem, Dalia, Gupta, Gaurav K., Roth, Mark, Filie, Armando C., Yates, Bonnie, Delbrook, Cindy, Derdak, Joanne, Mackall, Crystal L., Lee, Daniel W., Fry, Terry J., Wayne, Alan S., Stetler‐Stevenson, Maryalice, Shah, Nirali N., Dulau-Florea, Alina, Stetler-Stevenson, Maryalice
Formato:	research tables/charts Journal Article
Publicado:	Wiley-Blackwell Apr2020
Acceso en línea:	Ver este registro en EBSCOhost